0 of 15 enterprise AI mandates this week state budget ownership GSK’s AI Transformation & Enablement Director must build and defend the investment. Budget ownership is not stated.
14 captured listings and 1 announced appointment across 10 companies. These are mandate records, not a count of current vacancies.
Not stated means the frozen record does not state it. It does not mean the role has no budget. This Global 2000 sourcing sweep is not a market sample.
Our readThe read
GSK’s AI Transformation & Enablement Director is asked to “build and defend the investment behind it”. That is a useful sentence for a candidate: the strategy comes with an investment case to make. It still leaves a question unanswered: who can approve the spend? None of this week’s 15 frozen records states budget ownership. Gilead assigns product strategy and business value realization; Citi gives its risk director delegated authority. Those are different kinds of responsibility, and neither establishes control of money. Read the missing budget field alongside the mandate, then ask what authority makes delivery possible. This is a disclosure gap in the collected records, not proof that these leaders lack resources. The listings also include historical or uncertain availability; the mandate analysis is broader than the jobs block.
Subscribe
The weekly record of who companies hire to own enterprise AI.
One email a week, when email starts. Until then, you're on the list.
Records captured from 6 to 12 Oct 2026; posting and announcement dates can precede that window. All 15 records remain in the analysis, including closed and status-unknown listings. Availability has not been rechecked while drafting.
Number of the week
records state budget ownership. GSK asks its director to build and defend the investment; the budget field remains not stated.
All frozen mandate records, including the appointment and listings excluded from the jobs block.
Patterns
Counts from fixed rules over stated text (scripts/lib/editorial-rules.mjs, scripts/lib/buckets.mjs).
- Reporting lines3 of 15 records name one; 12 leave it unstated.
- Titles3 listings name governance, responsible AI or risk; 3 name build or delivery; 3 name adoption or transformation; 5 have general AI leadership titles.
- Pay11 of 14 captured listings state a range. These include historical and status-unknown records, and location conditions still apply.
- MovesGE HealthCare names Rodolphe Katra as Global Chief AI Officer in a public LinkedIn post, announced 29 Sep and captured 6 Oct.
Our readThe title categories describe where companies place the work. They cannot tell a candidate who controls resources. The stated reporting lines are a starting point for that conversation.
One chart
Who does the AI owner report to?
12 of 15 records do not say. Of the 3 that do, 2 name the head or director of an AI function; one names another line.
n = 15 records (14 listings, 1 appointments) · base: every record captured from 6 to 12 Oct 2026 in our Global 2000 coverage; listings posted 1 Oct to 11 Oct 2026 (0 undated); appointments announced 29 Sep to 29 Sep 2026 · not stated: listings 12 of 14 (86%), appointments 0 of 1 (0%) · caveat: a sourcing sweep, not a market sample; “stated” means the source text names a reporting line, and buckets are assigned by fixed rules from that verbatim text only · source: enterpriseaijobs.com/board
Read the mandate
AI Transformation & Enablement Director
“You will define the strategy and its multi-year roadmap, and build and defend the investment behind it.”
Reports to “the Head of Asset Acceleration and AI”. The mandate assigns strategy, a multi-year roadmap and an investment case. The location field is London, United Kingdom. The stated $179,850–$299,750 base range applies to new hires based in Cambridge, MA; Waltham, MA; Rockville, MD; or San Francisco, CA.
Budget ownership and delivery scope are not stated in the frozen record. It does not supply a team size or an investment amount.
Ask who approves the investment after the director defends it, and which decisions the director can make without another approval. The distinction matters when assessing whether the remit is executable. (Observed: the packet’s mandate, reporting line, location and conditional pay text. Inferred: the questions a candidate should ask.)
| Phrase in the posting | What it means Opinion |
|---|---|
define the strategy and its multi-year roadmap | The remit calls for planning beyond a single project. |
build and defend the investment behind it | An investment case is required; budget ownership is still unstated. |
Moves
1 appointments, all named from a public source in a public LinkedIn post.
- GE HealthCareAnnounced 29 Sep 2026Public LinkedIn post
Rodolphe Katra
Reports to
Reporting to Taha Kass-Hout
From the source:
Reporting to Taha Kass-Hout, and working closely with our segment teams, Rodolphe will help us take our AI strategy to the next level—connecting devices, software and data to deliver better insights, more longitudinal understanding and more precise care.
Our readThe announcement names the reporting line and connects the remit to devices, software and data. Budget ownership is not stated.
Announcement ↗
New roles
14 listings at 9 companies. Title, stated reporting line, scope and pay. 11 of 14 state a pay range. Each links to the board record and to the source.
- GSKPharma & life sciencesAssociate Director - BSO - IAI - Responsible AISource ↗
Reports toNot stated
- AstraZenecaHead of AI for ITSource ↗
Reports toNot stated
From the source:
The Head of AI for IT leads the execution of AstraZeneca’s AI-for-IT strategy, developing, deploying and scaling AI across the IT function.
Our readThe mandate places AI execution within IT. Ask how priorities across that function are set.
- CitiSenior AI Application Development Lead, Senior Vice PresidentSource ↗
Reports toNot stated
- GSKPharma & life sciencesAI Transformation & Enablement DirectorSource ↗
The stated pay range applies only to new hires in Cambridge, MA; Waltham, MA; Rockville, MD; or San Francisco, CA. The location field is London, United Kingdom.
Reports to
the Head of Asset Acceleration and AI
From the source:
You will define the strategy and its multi-year roadmap, and build and defend the investment behind it.
Our readAn investment case is part of the remit. Ask who approves it and whether the director can redirect spending.
- PfizerVice President, Applied AI & Architecture - US CommercialSource ↗
Reports toNot stated
From the source:
This role ensures that AI investments are technically sound, reusable, integrated, and aligned with Pfizer’s enterprise environment.
Our readTechnical soundness, reuse and integration define the mandate. Budget ownership remains not stated.
- Johnson & JohnsonHealthcareSenior Director, Medical AI and DataSource ↗
Reports toNot stated
- MastercardVice President- AI, Center of ExcellenceSource ↗
Captured mandate only; not presented as a current vacancy. Excluded from this issue’s jobs block.
Reports toNot stated
- SanofiPharma & life sciencesMarket Access AI & Data Management LeadSource ↗
Reports toNot stated
- Johnson & JohnsonHealthcareSenior Director, Global Commercial Data Platforms & AI EngineeringSource ↗
Status unknown in the frozen packet (status checked 13 Oct 2026). Retained for mandate analysis; excluded from the jobs block.
Reports to
the VP, Global Commercial Data Platforms and AI Products
- CitiAI Business Risk and Control DirectorSource ↗
Reports toNot stated
From the source:
You will operate with delegated authority, shape AI risk appetite, and serve as the senior escalation point for complex AI risk matters across a global portfolio.
Our readDelegated authority is explicit. The packet does not state budget ownership or a reporting line.
- Johnson & JohnsonHealthcareSenior Manager, Global Commercial Data & AI EnablementSource ↗
Closed in the frozen packet (status checked 13 Oct 2026). Retained for mandate analysis; excluded from the jobs block.
Reports toNot stated
- CitiBanking & lendingHead of AI Customer ExperienceSource ↗
Reports toNot stated
- Clifford ChanceProfessional servicesHead of AI and Technology RiskSource ↗
Reports toNot stated
- Gilead SciencesPharma & life sciencesDirector, Global AI Product Enablement - Medical AffairsSource ↗
Reports toNot stated
From the source:
As Director of Global AI Product Enablement, you will own the end-to-end product strategy, roadmap, and business value realization of AI capabilities across the Medical Affairs Technology (MAT) portfolio.
Our readProduct strategy and business value realization sit together in the mandate. Budget ownership is not stated.
What we're watching
Questions the next records could answer. Not predictions.
- Will a future mandate name the budget owner as clearly as it names the work?
- Will investment-case responsibilities come with explicit approval authority?
Corrections and weakest records
Mastercard’s Vice President- AI, Center of Excellence is retained as a captured mandate, not presented as a current vacancy. It is excluded from the jobs block under the editorial instruction for this issue. Johnson & Johnson’s Senior Manager, Global Commercial Data & AI Enablement is closed; its Senior Director, Global Commercial Data Platforms & AI Engineering has unknown status in the packet. Both remain in the analysis and are excluded from the jobs block. Borderline remits remain included. No live source checks were made during drafting.
Role-level moves: no public source names the person (0)
None this issue: every appointment is named from a public source.
Source liveness not checked for this issue (run npm run check-sources).
Subscribe
The weekly record of who companies hire to own enterprise AI.
One email a week, when email starts. Until then, you're on the list.